112 related articles for article (PubMed ID: 10906559)
1. The role of nutrients in the prevention of cervical dysplasia and cancer.
Giuliano AR
Nutrition; 2000; 16(7-8):570-3. PubMed ID: 10906559
[No Abstract] [Full Text] [Related]
2. Old and new issues in cervical cancer control.
Critchlow CW; Kiviat NB
J Natl Cancer Inst; 1999 Feb; 91(3):200-1. PubMed ID: 10037093
[No Abstract] [Full Text] [Related]
3. Human papillomavirus variants: implications for natural history studies and vaccine development efforts.
Hildesheim A
J Natl Cancer Inst; 1997 Jun; 89(11):752-3. PubMed ID: 9182967
[No Abstract] [Full Text] [Related]
4. Global challenges of cervical cancer prevention.
Monsonego J
Clin Exp Obstet Gynecol; 2001; 28(1):5-13. PubMed ID: 11332590
[No Abstract] [Full Text] [Related]
5. Human papillomavirus and other risk factors for cervical cancer.
Bosch FX; Muñoz N; de Sanjosé S
Biomed Pharmacother; 1997; 51(6-7):268-75. PubMed ID: 9309247
[TBL] [Abstract][Full Text] [Related]
6. The need for forward-looking decision analyses to guide cervical cancer prevention.
Schiffman M
Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):219-20. PubMed ID: 21300615
[No Abstract] [Full Text] [Related]
7. Vaccines against papillomavirus infections and disease.
Villa LL
Rev Chilena Infectol; 2006 Jun; 23(2):157-63. PubMed ID: 16721451
[No Abstract] [Full Text] [Related]
8. [The role of tumor-related papillomavirus infection of the genitals in the genesis of background pathology of the ectocervix, dysplasia and preinvasive cancer of the cervix uteri].
Maksimov SIa; Savicheva AM; Bashmakova MA; Shaimardanova GI; Shipitsina EV; Rybina EV
Vopr Onkol; 1999; 45(6):627-9. PubMed ID: 10703510
[No Abstract] [Full Text] [Related]
9. A human papillomavirus type 16 vaccine.
Gambacorti CB
N Engl J Med; 2003 Apr; 348(14):1402-5; author reply 1402-5. PubMed ID: 12678022
[No Abstract] [Full Text] [Related]
10. Testing for human papillomavirus in women with abnormal pap smear results.
McCaffery KJ; Waller J; Forrest S; Wardle J
JAMA; 2002 Sep; 288(11):1350; author reply 1351-2. PubMed ID: 12234219
[No Abstract] [Full Text] [Related]
11. [Cervix dysplasia and cervix carcinoma].
Bol P
Ned Tijdschr Tandheelkd; 1998 Dec; 105(12):455-6. PubMed ID: 11928150
[No Abstract] [Full Text] [Related]
12. Stop cervical cancer in its tracks.
Bence SA
Nurse Pract; 2000 Apr; 25(4):16-7. PubMed ID: 10790794
[No Abstract] [Full Text] [Related]
13. Human papillomavirus types and cervical cancer.
Apgar BS
Hosp Pract (1995); 1996 Feb; 31(2):39-40, 43. PubMed ID: 8592014
[No Abstract] [Full Text] [Related]
14. Vaccinating adolescents and young women against cancer of the cervix.
Hilgers RD; Wyatt SW
J Ky Med Assoc; 2007 May; 105(5):215-6. PubMed ID: 17566465
[No Abstract] [Full Text] [Related]
15. Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine.
Prescrire Int; 2008 Jun; 17(95):103-4. PubMed ID: 18623911
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus type distribution among women with cervical pathology - a study over 4 years at Jimma Hospital, southwest Ethiopia.
Bekele A; Baay M; Mekonnen Z; Suleman S; Chatterjee S
Trop Med Int Health; 2010 Aug; 15(8):890-3. PubMed ID: 20545913
[TBL] [Abstract][Full Text] [Related]
17. Precursor lesions of the cervix.
Moore MD
NAACOGS Clin Issu Perinat Womens Health Nurs; 1990; 1(4):513-24. PubMed ID: 1964388
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing cervical cancer screening in women infected with HIV: a review of the literature.
Chapman Lambert CL
J Assoc Nurses AIDS Care; 2013; 24(3):189-97. PubMed ID: 22999769
[TBL] [Abstract][Full Text] [Related]
19. [Human papilloma virus and cervical cancer].
Kawana T
Gan To Kagaku Ryoho; 1995 May; 22(6):711-7. PubMed ID: 7755378
[TBL] [Abstract][Full Text] [Related]
20. [A study on the relationship between cervical carcinoma, dysplasia and sexually transmitted diseases].
Hu W; Gu M
Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):547-9. PubMed ID: 8556916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
